INCY vs ST · P/E 14, rev $5.14B vs P/E 150, rev $1.93B
Incyte Corporation (INCY) versus Sensata Technologies Holding NV (ST) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Sensata Technologies Holding NV (ST) is a scientific & technical instruments company listed on NYSE.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported ST revenue for 2026-06-30 was $1.93B. Net income was $189.2M. ST currently screens at market cap $7.19B and trailing P/E 149.9.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. ST currently screens at market cap $7.19B and trailing P/E 149.9.
Not investment advice. Open the INCY and ST stock pages for the full models.
Not investment advice.